◆英語タイトル:University of Wisconsin Madison - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013489
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月28日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
University of Wisconsin Madison (UW-Madison), a subsidiary of University of Wisconsin System is an educational and research institution that provides undergraduate and postgraduate courses. The institution offers courses in various fields such as agricultural and life sciences, arts, business, engineering, graduate school, law school, nursing, veterinary medicine, public affairs, medicine and public health and library and information studies, among others. It also organizes youth programs such as Badger summer sports camps, PEOPLE Program, Saturday Enrichment, and Summer Science Institute. The institution’s research centers include Agribusiness Institute, Antarctic Meteorological Research Center, Aquatic Sciences Center, Biotechnology Center, Cardiovascular Research Center and Environmental Remote Sensing Center, among others. UW-Madison is headquartered in Madison, Wisconsin, the US.
University of Wisconsin Madison – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Wisconsin Madison, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Wisconsin Madison, Medical Devices Deals, 2011 to YTD 2017 9
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
FluGen Raises USD12 Million in Series A Financing 12
Madison Vaccines Raises Additional USD2 Million in Series A Financing 13
Madison Vaccines Raises US$8 Million In Series A Financing 14
ProCertus BioPharm Raises An Additional US$1.7 Million In Series A Venture Financing 16
Partnerships 17
Revive Therapeutics Enters into Research Agreement with University of Wisconsin Madison 17
NanoViricides Enters into Agreement with University of Wisconsin-Madison 18
Janssen Pharma Enters into Agreement with University of Wisconsin-Madison 19
Morphotek Enters into Research Agreement with University of Wisconsin Madison 20
UW Institute for Clinical and Translational Research to Form Partnership with German Center for Neurodegenerative Diseases 21
Licensing Agreements 22
AhR Pharma Enters Into Licensing Agreement With WARF For Cancer Fighting Hormone 22
Cellular Dynamics International Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 23
AllCells Enters Into Licensing Agreement With Wisconsin Alumni Research Foundation And WiCell Research Institute 24
Epi Pharma Amends Licensing Agreement with John Hopkins University, Wayne State University and Wisconsin Alumni Research Foundation 25
Equity Offering 26
Co-D Therapeutics Spin Off from University of Wisconsin Madison 26
University of Wisconsin Madison – Key Competitors 27
University of Wisconsin Madison – Key Employees 28
University of Wisconsin Madison – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Government and Public Interest 30
Oct 23, 2017: New study shows how cells can be led down non-cancer path 30
Jul 14, 2017: Advance furthers stem cells for use in drug discovery, cell therapy 32
Jun 27, 2017: Morgridge scientists illuminate structures vital to virus replication 33
Jul 18, 2016: Macular degeneration insight identifies promising drugs to prevent vision loss 35
Jan 12, 2016: New NIH awards will support development of therapeutic alternatives to traditional antibiotics 37
Product News 39
Jan 24, 2017: Watching gene editing at work to develop precision therapies 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40
List of Tables
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Key Facts 2
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Wisconsin Madison, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Wisconsin Madison, Deals By Therapy Area, 2011 to YTD 2017 8
University of Wisconsin Madison, Medical Devices Deals, 2011 to YTD 2017 9
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
FluGen Raises USD12 Million in Series A Financing 12
Madison Vaccines Raises Additional USD2 Million in Series A Financing 13
Madison Vaccines Raises US$8 Million In Series A Financing 14
ProCertus BioPharm Raises An Additional US$1.7 Million In Series A Venture Financing 16
Revive Therapeutics Enters into Research Agreement with University of Wisconsin Madison 17
NanoViricides Enters into Agreement with University of Wisconsin-Madison 18
Janssen Pharma Enters into Agreement with University of Wisconsin-Madison 19
Morphotek Enters into Research Agreement with University of Wisconsin Madison 20
UW Institute for Clinical and Translational Research to Form Partnership with German Center for Neurodegenerative Diseases 21
AhR Pharma Enters Into Licensing Agreement With WARF For Cancer Fighting Hormone 22
Cellular Dynamics International Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 23
AllCells Enters Into Licensing Agreement With Wisconsin Alumni Research Foundation And WiCell Research Institute 24
Epi Pharma Amends Licensing Agreement with John Hopkins University, Wayne State University and Wisconsin Alumni Research Foundation 25
Co-D Therapeutics Spin Off from University of Wisconsin Madison 26
University of Wisconsin Madison, Key Competitors 27
University of Wisconsin Madison, Key Employees 28
University of Wisconsin Madison, Subsidiaries 29